Who is Organovo?
- We participate in attractive and growing markets with critical unmet needs
- We benefit from favorable competitive dynamics and a first mover advantage
- We’re a technology leader with a strong IP portfolio
- We’re leveraging our technology platform to build a robust product and service platform across the high-value drug profiling and therapeutic tissues markets
|2017 Annual Report||Investor Fact Sheet||Investor Presentation|
|Recent Investor NewsInvestor Events|
|Latest TweetsTweets by @OrganovoIR|